###begin article-title 0
###xml 63 73 63 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus
###end article-title 0
###begin p 1
Present addresses: Emilie Auriol and Robert Dante, Unite INSERM 590, Laboratoire d'Oncologie Moleculaire, Centre Leon Berard, 28 rue Laennec, 69373 Lyon Cedex 08, France
###end p 1
###begin p 2
Frederique Magdinier, Laboratoire de Biologie Moleculaire de la Cellule, CNRS UMR 5161-ENS, Lyon, France
###end p 2
###begin p 3
###xml 606 642 606 642 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oupjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
###end p 3
###begin p 4
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 742 747 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 748 752 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 804 808 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 898 902 886 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 946 950 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 1010 1014 998 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 1110 1115 1098 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
The methyl-CpG binding domain (MBD) proteins are key molecules in the interpretation of DNA methylation signals leading to gene silencing. We investigated their binding specificity at the constitutively methylated region of a CpG island containing the bidirectional promoter of the Breast cancer predisposition gene 1, BRCA1, and the Near BRCA1 2 (NBR2) gene. In HeLa cells, quantitative chromatin immunoprecipitation assays indicated that MBD2 is associated with the methylated region, while MeCP2 and MBD1 were not detected at this locus. MBD2 depletion (approximately90%), mediated by a transgene expressing a small interfering RNA (siRNA), did not induce MeCP2 or MBD1 binding at the methylated area. Furthermore, the lack of MBD2 at the BRCA1-NBR2 CpG island is associated with an elevated level of NBR2 transcripts and with a significant reduction of induced-DNA-hypomethylation response. In MBD2 knockdown cells, transient expression of a Mbd2 cDNA, refractory to siRNA-mediated decay, shifted down the NBR2 mRNA level to that observed in unmodified HeLa cells. Variations in MBD2 levels did not affect BRCA1 expression despite its stimulation by DNA hypomethylation. Collectively, our data indicate that MBD2 has specific targets and its presence at these targets is indispensable for gene repression.
###end p 4
###begin title 5
INTRODUCTION
###end title 5
###begin p 6
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
In mammals, DNA methylation at CpG islands located within regulatory regions is a crucial event in gene silencing. The various mechanisms leading to methylation-dependent down-regulation of the transcription remain to be fully determined. However, the discovery of methyl-CpG binding domain (MBD) proteins and their interacting partners provides a direct link between DNA methylation and the establishment of a repressive chromatin architecture (1). The five MBD proteins identified to date share the functional MBD (2). Four of them, MBD1, MBD2, MBD3 and MeCP2, are directly involved in the transcriptional repression of methylated templates in vertebrates and, with the exception of MBD3, bind methylated DNA (3).
###end p 6
###begin p 7
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 365 370 <span type="species:ncbi:10090">mouse</span>
MeCP2, the founding member of the MBD family, represses transcription through its interactions with the histone deacetylase-Sin3 complex and the histone 3 lysine 9 trimethyl-transferase Suv39H1 (4-6). MBD3 is part of the histone deacetylase and chromatin remodeling Mi2/NuRD complex, which is targeted to methylated templates in the MeCP1 complex by MBD2 (7,8). In mouse, an interaction between the MBD2 and the Sin3 complex has also been described previously (9). The HDAC complex associated with MBD1 is not yet identified (10), but other MBD1 partners such as histone 3 lysine 9 dimethyl transferase SETDB1 and the chromatin assembly protein 1 have been characterized previously (11,12).
###end p 7
###begin p 8
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 329 338 329 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U2af1-rs1</italic>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MeCP2</italic>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 900 905 900 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1071 1075 1071 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd1</italic>
###xml 1075 1078 1075 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 1428 1430 1428 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
###xml 666 671 <span type="species:ncbi:9606">human</span>
###xml 885 890 <span type="species:ncbi:10090">mouse</span>
###xml 968 976 <span type="species:ncbi:9606">patients</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
In cell lines, MBD1, MBD2 and MeCP2 transiently repress the expression of genes driven by either strong or weak promoters (13), suggesting some functional redundancies between these proteins. Moreover, both the MBD1 and the MeCP2 proteins are associated, in vivo, with the differentially methylated region of the mouse imprinted U2af1-rs1 gene (14) and, in cancer cell lines, some methylated CpG islands are bound by multiple MBD proteins (15). Since many cell and tissue types express multiple MBD proteins, these data suggest that other members of the family might compensate the absence of a specific MBD. However, functional specificities have been observed. In human, MeCP2 mutations are the cause of the RETT syndrome (RTT), a neurological disorder associated with motor function impairment that represents one of the most common causes of mental retardation in females (16). In mouse, loss of Mecp2 leads to phenotypes that resemble some of the symptoms of RTT patients (17,18), indicating a specific function of MeCP2 in the maturation of central nervous system. Mbd1-/- mice also show neuronal maturation deficits associated with hippocampal functions (19). Therefore, the involvement of these proteins in different pathways of the central nervous system argues against a functional redundancy between Mecp2 and Mbd1. In addition, mice lacking Mbd2 do not exhibit specific phenotype except a maternal behavior deficit (20).
###end p 8
###begin p 9
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLX5</italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd1</italic>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 662 665 662 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 758 761 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL4</italic>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 187 190 <span type="species:ncbi:10116">rat</span>
###xml 481 486 <span type="species:ncbi:10090">mouse</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
Although no global misexpression of endogenous methylated genes has been detected in the first studies, candidate gene approaches have identified some specific target genes. In mouse and rat, Mecp2 is directly involved in a depolarization-controlled repression of the brain derived neurotrophic factor gene in neurons (21,22), and that of the imprinted DLX5 gene driven at a distance by Mecp2 has also been shown previously (23). Specific repression is not restricted to MeCP2. In mouse, loss of Mbd1 induces small but significant increase in the expression of the endogenous virus, IAP, associated with chromosome instability in cultured neuron cells (19). Mbd2-/- mice exhibit a disordered helper T cells differentiation owing to ectopic expression of the IL4 gene (24).
###end p 9
###begin p 10
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 23 28 <span type="species:ncbi:9606">human</span>
A comparative study in human cancer cell lines using a chromatin immunoprecipitation (ChIP) assay combined with a CpG island microarray also suggests some specificities, since some cancer-associated hypermethylated genes are bound by multiple MBD proteins while others are associated with a single MBD protein (15). Furthermore, in interphase MCF7 cells, the distribution of MeCP2 does not parallel that of methylated cytosine and heterochromatin, and a selective binding of MeCP2 to some repetitive elements has also been observed previously (25). The mechanisms driving the MBD binding are not yet fully determined. The relative abundance of the MBD proteins might be an important parameter, since it was suggested that there are more methyl-CpGs in the genome than MBD protein molecules (1), and whether MBD1, MBD2 and MeCP2 are randomly associated with sites or segregate owing to other constraints is not yet known.
###end p 10
###begin p 11
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 461 466 <span type="species:ncbi:9606">human</span>
To address this question, we investigated in HeLa cells, the MBD proteins binding pattern at a CpG island located in the 5' end of the Breast cancer predisposition gene 1 (BRCA1). BRCA1 lies head to head with the Near BRCA1 2 gene (NBR2) (26). Experiments of site-directed deletions led to the identification of a bidirectional promoter that is embedded within a large CpG island (13). This CpG island contains a region that is constitutively methylated in all human cell lines and tissues, except gametes and preimplantation embryos (27-29). Therefore, this model represents an interesting tool for investigating MBD proteins binding specificity and their effects on transcription at a naturally methylated CpG island.
###end p 11
###begin title 12
MATERIALS AND METHODS
###end title 12
###begin title 13
Cell culture
###end title 13
###begin p 14
###xml 239 240 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 175 179 <span type="species:ncbi:9913">calf</span>
Cervix cancer cell line (HeLa) was obtained from ATCC (Rockville, MD) and grown in minimum essential medium (Eagle; Sigma, L'isle d'Abeau, France) supplemented with 10% fetal calf serum. Cells were grown at 37degreesC in a humidified 5% CO2 atmosphere.
###end p 14
###begin title 15
5-Aza-2'-deoxycytidine treatments
###end title 15
###begin p 16
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
For 5-aza-2'-deoxycytidine (5-aza-dC; Sigma) treatments, cell lines were seeded at low density (3-4 x 105 cells/100 mm dish) 16 h before treatment with a final concentration of 10 muM 5-aza-dC. The medium was changed after 24 h drug addition and every subsequent day. RNAs were isolated after 72 h.
###end p 16
###begin title 17
Cell transfections
###end title 17
###begin p 18
###xml 379 382 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
pCMV-MeCP2-HA (kindly provided by Dr A. Bird), pRev-MBD2 (modified from pCMV-MBD2, kindly provided by Dr A. Bird) and pGL3 basic (Promega, Lyon, France) were transfected using the Exgen500 transfection reagent, according to the manufacturer's instructions (Euromedex, Mundolsheim, France). Cells were collected 48 h after transfection. Transfection efficiency was tested using a CMV-lacZ vector and beta-galactosidase activity was observed in >90% of the cells.
###end p 18
###begin title 19
Quantification of nucleic acids
###end title 19
###begin p 20
Nucleic acids were quantified by densitometry using the Fluorimeter Fluors and the Quantity One software (BioRad, Ivry, France), either from agarose gel containing 1 mug/ml ethidium bromide or dots mixed with an equal volume of a 200-fold diluted solution of RiboGreen (Molecular Probes, Interchim, Montlucon, France).
###end p 20
###begin title 21
RNA extraction and quantitative RT-PCR
###end title 21
###begin p 22
###xml 323 327 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 611 615 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 1016 1021 1014 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1026 1030 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 1095 1097 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1098 1100 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 967 972 <span type="species:ncbi:4932">yeast</span>
Total RNA was extracted from cell lines with the RNeasy kit (Qiagen, Courtaboeuf, France) and treated with DNase I using the DNA-free kit (Ambion Inc., Cambridgeshire, UK). After extraction, the integrity of total RNA was examined on a 1.2% agarose gel containing 1 mug/ml ethidium bromide and quantified. cDNA fragment of NBR2 (from position +146 to +604 from the transcription start site) was amplified by RT-PCR using forward 5'-GAGGTCTCCAGTTTCGGTAA-3' and reverse 5'-GAACCAAGGTGAAGGACCAA-3'. After cloning the PCR product into a pGEM-T easy vector (Promega), a 109 bp long deletion was performed within the NBR2 cDNA using the restriction endonuclease MaeIII (Roche, Meylan, France). The competitor RNA was synthesized using the Sp6 RNA polymerase according to the manufacturer's instructions (Promega). After DNase I digestion (Ambion Inc.) and RNeasy purification (Qiagen), this competitor RNA was quantified by densitometry and then diluted in the presence of yeast tRNA as a carrier (40 ng/mul; Ambion). For BRCA1 and MBD2 quantitative RT-PCR, previously designed competitors were used (30,31).
###end p 22
###begin p 23
###xml 48 52 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 66 71 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 88 92 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 228 232 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 540 544 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 549 553 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 570 575 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1213 1215 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
Equal amounts of total RNA samples (0.6 mug for NBR2, 0.3 mug for BRCA1 and 0.1 mug for MBD2) were coamplified with increasing amounts of competitor RNAs in a final volume of 50 mul using the One Step RT-PCR kit, Q solution for NBR2 (Qiagen) and 0.6 muM of each primers. After a 30 min incubation at 50degreesC, RT was inactivated by heating at 95degreesC for 15 min. The PCR amplification was then accomplished in a thermocycler under the following conditions: 35 cycles, 30 s denaturation at 94degreesC, 1 min annealing at 62degreesC for NBR2 and MBD2, 64degreesC for BRCA1 and 1 min 30 s extension at 72degreesC. In addition, control experiments for each competitor RNA were performed by omitting the RT to ensure that the signal was the result of RNA and not DNA amplification. PCR products were analyzed on a 2% agarose gel and quantified. Then, the normalized signals corresponding to the target mRNA and the competitor were plotted against the initial number of competitor molecules added to the test tubes. The abscissa of the intersection of the curves represents an estimation of the equivalence point between the initial amount of the competitor molecules and the number of copies of the mRNA assayed (32).
###end p 23
###begin title 24
Protein extraction and western blot analysis
###end title 24
###begin p 25
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 183 189 <span type="species:ncbi:9986">rabbit</span>
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
###xml 415 421 <span type="species:ncbi:9986">rabbit</span>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
Forty micrograms of whole cell lysates were separated by electrophoresis through SDS-10% polyacrylamide gels and analyzed by western blot (31). For the detection of the MBD proteins, rabbit polyclonal antibodies against MBD2 (kindly provided by Dr P. Wade) or MeCP2 (Upstate Biotechnology, Lake Placid, NY) and mouse monoclonal antibody against MBD1 (Abgent, San Diego, CA), were diluted 1/2000. The secondary anti-rabbit-HRP or anti-mouse-HRP conjugate antibodies were diluted 1/5000. The immunocomplexes were detected using the ECL system (Amersham, Saclay, France).
###end p 25
###begin title 26
Quantitative chromatin immunoprecipitation
###end title 26
###begin p 27
###xml 286 289 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 445 446 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 2070 2071 2058 2059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1522 1527 <span type="species:ncbi:10090">mouse</span>
###xml 1660 1666 <span type="species:ncbi:9986">rabbit</span>
###xml 1683 1688 <span type="species:ncbi:10090">mouse</span>
###xml 2164 2169 <span type="species:ncbi:10090">mouse</span>
Cells were washed and scraped off the culture dishes in phosphate-buffered saline, and nuclei were prepared in ice-cold hypotonic buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl and 5 mM MgCl2). Each step was performed on ice and in the presence of a mixture of protease inhibitors (Complete(R); Roche). After centrifugation, cells were lyzed in the hypotonic buffer containing 0.1% NP-40. Nuclei were harvested by centrifugation at 2000 r.p.m. (700 g) and were washed in the same buffer. Nuclear proteins were then cross-linked to DNA by an incubation with 1% formaldehyde for 10 min at room temperature and then for 40 min at +4degreesC. Cross-linking was stopped by adding 125 mM glycine for 5 min. After centrifugation, the pellets were washed in the hypotonic buffer and resuspended in 1-2 ml of SDS lysis buffer (1% SDS, 10 mM EDTA and 50 mM Tris-HCl, pH 8). Nucleoprotein complexes were sonicated to reduce the length of DNA fragments to 300-600 bp. Insoluble material was removed and the supernatant was collected. Thirty microliters of this fraction was preserved as an input control and the rest was diluted 1:10 in ChIP dilution buffer (ChIP assay Kit; Upstate Biotechnology). The chromatin solution was precleared for 1 h by incubation with 80 mul of salmon sperm DNA-protein A-agarose beads (Upstate Biotechnology). The soluble fraction was collected and 15 mul of monoclonal anti-MBD1 (Abgent), polyclonal anti-MBD1 (Abcam, Cambridge, UK), anti-MBD2 (kindly provided by Dr P. Wade), anti-MeCP2 (Upstate) and anti-mouse IgG (Dakocytomation, Trappes, France) antibodies were added and incubated overnight. Then, for ChIP monoclonal antibodies, 1 mug of rabbit polyclonal anti-mouse antibody (Dakocytomation) was added and incubated for 1 h. After immunoprecipitation, immune complexes were collected by adding 60 mul of salmon sperm DNA-protein A-agarose beads for 1 h. The supernatant corresponding to the unbound fraction was collected. After washing (according to the manufacturer's instructions), complexes were eluted from the beads in 1% SDS and 0.1 M NaHCO3. This fraction corresponds to the bound (anti-MBD) or the non-MBD-specific antibodies (anti-mouse IgG) fractions. Cross-links were reversed by heating samples at 65degreesC in 200 mM NaCl. DNA was recovered by proteinase K digestion, phenol extraction and ethanol precipitation. Finally, DNA samples from the input, unbound, non-MBD-specific antibody and bound fractions were quantified.
###end p 27
###begin p 28
###xml 89 99 89 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 844 847 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 963 966 961 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1352 1357 1325 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1654 1664 1627 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
Quantitative PCR amplification was performed using a competitor DNA. DNA fragment of the BRCA1-NBR2 CpG island (from position -1244 to -1004 from the BRCA1 transcription start site, fragment A) was amplified by PCR using forward 5'-GCTTTTCGCCCACTCGGTCC-3' and reverse 5'-CAGAGCTGGCAGCGGACGGT-3'. After cloning the PCR product into a pGEM-T easy vector (Promega), a single cut within the island fragment was performed using AccIII and an insertion of a 43 bp chemically synthesized duplex-oligonucleotide was accomplished using T4 DNA ligase (Roche). After cloning and purification (Plasmid Maxi Kit; Qiagen), this competitor vector was quantified. Equal amounts (2 ng) of total DNA samples from the input, unbound and bound fractions were coamplified with increasing amounts of competitor plasmid in a final volume of 100 mul using the HotStar Taq polymerase kit (Qiagen) and 0.4 muM of each primer. The PCR amplification was accomplished after activation of the Taq polymerase (15 min at 95degreesC and 35 cycles in a thermocycler under the following conditions: 30 s denaturation at 94degreesC, 1 min annealing at 63degreesC and 1 min 30 s extension at 72degreesC). PCR products were analyzed on a 2% agarose gel containing 1 mug/ml ethidium bromide and were quantified by densitometry as described. Then, the normalized signals corresponding to the BRCA1 CpG island fragment and the competitor were plotted against the initial quantity of competitor molecules added to the test tubes. The abscissa of the intersection of the curves represents an estimation of the equivalence point between the initial amount of the competitor and the quantity of the BRCA1-NBR2 CpG island fragment in each sample (Supplementary Figure 8s).
###end p 28
###begin p 29
###xml 55 65 55 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
We also analyzed three other regions of the methylated BRCA1-NBR2 CpG island (B, C and D fragments) by performing a semi-quantitative PCR. We amplified equal amounts of total DNA samples (0.5 ng) from the input, unbound and bound fractions, using forward 5'-AAGGGCTCCTCCAGCACGGC-3' and reverse 5'-TTCTGAGGGACCGAGTGGGC-3' for the B fragment (from positions -1364 to -1218 from the BRCA1 transcription start site); forward 5'-TTCAAGCGGGGTGCAGGCGG-3' and reverse 5'-CCCTCTCTGGGCTGGCCGAA-3' for the C fragment (from positions -1389 to -1637); forward 5'-CTGGTGCATATAAAATCCTCAGGC-3' and reverse 5'-GCACAGGGCAAGGCTCAGGA-3' for the D fragment (from positions -1653 to -1928).
###end p 29
###begin p 30
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
As a control, we amplified an unmethylated region including the promoter and the exon 1 of the BRCA1 gene ('promoter fragment' from position -56 bp to +263 bp) using forward 5'-TAGCCCTTGGGTTCCGTG-3' and reverse 5'-TCACAACGCCTTACGCCTC-3'.
###end p 30
###begin p 31
###xml 68 71 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 326 331 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 480 490 448 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
PCR was accomplished in a final volume of 100 mul using the HotStar Taq polymerase kit (Qiagen) and 0.4 muM of each primer, as described previously, under the following conditions: 30 s denaturation at 94degreesC, 1 min annealing at 64degreesC for the fragment B, 66degreesC for the fragments C and D or at 60degreesC for the BRCA1 promoter, and 1 min 30 s extension at 72degreesC. PCR products were analyzed and quantified by densitometry. Then, the signals corresponding to the BRCA1-NBR2 CpG island fragment in the input, unbound and bound fractions were compared.
###end p 31
###begin title 32
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
Stable knockdown of MBD2 by short interfering RNA and transient reversion
###end title 32
###begin p 33
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 125 129 125 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</sub>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 565 569 565 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</sub>
###xml 874 878 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
HeLa cells stably expressing small interfering RNA (siRNA) were established as described previously (33). Briefly, the pSUPERMBD2 plasmid was generated by cloning the 19 nt sequence 5'-GGAGGAAGTGATCCGAAAA-3' (beginning 575 nt from the translation start site in the mouse MBD2 mRNA), separated by a spacer from its reverse complement as a BglII/HindIII fragment (synthesized at Proligo, Paris, France) into the pSUPER vector. This vector directs synthesis of RNA from the polymerase III-H1-RNA promoter that is processed in the cell to siRNA. One microgram of pSUPERMBD2 was cotransfected with 0.1 mug of a plasmid encoding a geneticin resistance gene into HeLa cells by using Lipofectamine 2000 (Invitrogen, Cergy Pontoise, France). Cells were selected using 1 mug/ml G418 (Roche) for 15 days. Clones were picked and expanded for an additional 20 days and were analyzed for MBD2 mRNA and protein levels as described previously.
###end p 33
###begin p 34
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 216 217 216 217 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 220 221 220 221 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 223 224 223 224 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 226 227 226 227 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 229 230 229 230 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 1092 1096 1092 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
Transient reversion of RNA interference (RNAi) was performed by transfecting HeLa clones with a pRev-MBD2 vector in which Mbd2 cDNA sequence was modified at the siRNA-target site. Despite five point mutations (5'-GGAAGA GGTCATTCGCAAA-3', mutated nucleotides are underlined) and also according to the genetic code, the new cDNA sequence encodes a functional Mbd2 protein. This vector was generated by digesting the pCMV-MBD2 vector (kindly provided by Dr A. Bird) within the Mbd2 cDNA sequence with KspI (Roche) and AccIII (Promega) endonucleases. This KspI/AccIII fragment was gel-purified (MinElute gel purification Kit; Qiagen) and digested by ApaI and AccI (Roche). A 117 bp double-stranded oligonucleotide (Eurogentec, Seraing, Belgium), containing the five silent point mutations, was introduced into ApaI/AccI site to replace the initial 117 bp fragment. After cloning and sequencing (Biofidal, Vaulx-en-Velin, France), plasmids exhibiting the expected sequence were selected. The transcription of the mutated form of Mbd2 cDNA allows this mRNA to bypass siRNA-mediated decay. HeLa and MBD2 knockdown clones were transfected with the resulting vector. Finally, MBD2 protein expression was assessed after cellular proteins extraction and western blotting.
###end p 34
###begin title 35
Sodium bisulfite modification
###end title 35
###begin p 36
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
The sodium bisulfite modification method, followed by the endonuclease restriction of PCR products, was used to determine the CpG methylation pattern. Sodium bisulfite converts unmethylated cytosines to uracils whereas the methylated cytosines remain unmodified. In the resultant modified DNA, uracils are replicated as thymines during PCR amplification (34).
###end p 36
###begin p 37
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 642 645 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 932 935 924 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
DNA was extracted from cell lines with the QiaAmp DNA Mini Kit (Qiagen). After extraction, the integrity of total DNA was examined on a 1.2% agarose gel and quantified by densitometry. The sodium bisulfite reaction was carried out as described previously (28). DNA was amplified using strand-specific primers designed to amplify a 304 bp region (methylated region, -1246 to -942 bp from the BRCA1 transcription start site) and a 250 bp region (unmethylated region, -592 to -343 bp from the BRCA1 transcription start site) in the CpG island of the BRCA1 gene. The first round of PCR amplification was accomplished in 100 mul using the HotStar Taq DNA polymerase Kit (Qiagen) and 0.4 muM of the primers (methylated region: forward 5'-TTTTGTTTTGTGTAGGGCGGTT-3' and reverse 5'-CCTTAACGTCCATTCTAACCGT-3'; unmethylated region: forward 5'-GTTTATAATTGTTGATAAGTATAAG-3' and reverse 5'-CCCACTCTTTCCGCCCTAAT-3') after 15 min at 95degreesC for Taq polymerase activation and 35 cycles (30 s denaturation at 94degreesC, 1 min annealing at 55degreesC for the methylated region or at 56degreesC for the unmethylated region, and 1 min 30 s extension at 72degreesC). An aliquot of the first amplification of the methylated region was reamplified with internal primers (forward 5'-TGAGAATTTAAGTGGGGTGT-3' and reverse 5'AACCCTTCAACCCACCACTAC-3') with the same conditions. PCR products were then analyzed by digestion with the restriction enzymes, CfoI (Roche) and HphI (NEN Biolabs, Saint Quentin Yvelines, France). Digestion products were analyzed on a 2% agarose gel containing 1 mug/ml ethidium bromide.
###end p 37
###begin title 38
RESULTS
###end title 38
###begin title 39
###xml 79 89 79 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
MBD2 binds to the methylated region of a CpG island flanking the bidirectional BRCA1-NBR2 promoter
###end title 39
###begin p 40
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 107 115 107 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 363 365 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 366 368 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 508 510 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
A large CpG island, 2.8 kb in length, lying from nt -1810 to +974 from the BRCA1 transcription start site (Figure 1) exhibits several features, suggesting that it might be a target for MBD proteins. Indeed, this CpG island is unmethylated in gametes, but regionally methylated (position -2000 to approximately-1000) in all tissues and cell lines so far analyzed (27-29), and nuclease protection assays indicate that this methylated region is embedded in a condensed chromatin structure in breast cell lines (29) and in HeLa cells (data not shown).
###end p 40
###begin p 41
###xml 136 144 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 391 400 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 482 487 <span type="species:ncbi:10090">mouse</span>
Quantitative ChIP assays were performed using antibodies directed against MBD1, MBD2 and MeCP2. The analyzed region (nt -1244 to -1004; Figure 1, 'A' segment) is located close to, but does not overlap with, the repetitive element LTR12c (nt -3125 to -1276), which is part of the CpG island (Figure 1). Data obtained from at least three independent ChIP assays for each antibody are shown in Figure 2A. The fractions immunoprecipitated with a non-MBD protein specific antibody (anti-mouse IgG) did not contain enough DNA for PCR assay, indicating an efficient preclearing step.
###end p 41
###begin p 42
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 127 136 127 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 220 229 208 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 295 305 283 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 489 499 477 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 618 627 606 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
When antibodies against MBD2 are used, the amount of BRCA1-NBR2 CpG island per ng of total DNA in immunoprecipitated fraction (Figure 2A, 'bound') is higher (approximately5-fold) than in input or non-retained fractions (Figure 2A, 'input' and 'unbound'). Therefore, these data indicate that the BRCA1-NBR2 CpG island is specifically immunoprecipitated by the anti-MBD2 antibodies. In contrast, when antibodies against MeCP2 or MBD1 are used, the immunoprecipitated fraction is depleted in BRCA1-NBR2 CpG island, since the DNA segment is less abundant in the bound fraction than in the input and the unbound fractions (Figure 2A).
###end p 42
###begin p 43
###xml 134 143 134 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 223 233 223 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 464 473 464 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 798 807 798 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
A dose-dependent amplification of the 'B' region (nt -1364 to -1218) was performed on each fraction obtained from the ChIP procedure (Figure 2B). As observed at the segment lying from position -1244 to -1004, enrichment in BRCA1-NBR2 CpG island DNA in the bound fraction is only observed when the chromatin is immunoprecipitated with anti-MBD2 antibodies, while ChIPs with anti-MeCP2 or anti-MBD1 antibodies lead to a depletion of this DNA in the bound fractions (Figure 2B). MBD2 binding to the methylated part of the repeated LTR12c element was further investigated by performing ChIP assays at the 'C' region (nt -1389 to -1637) and 'D' region (nt -1653 to -1928). A significant enrichment of these fragments in the chromatin fraction immunoprecipitated by antibodies against MBD2 was observed (Figure 2B).
###end p 43
###begin p 44
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 197 207 197 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 308 317 308 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 462 472 462 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
We also amplified an unmethylated region containing the promoter and the exon 1 of the BRCA1 gene (from position -56 to +263 bp from the BRCA1 transcription start site). As expected, enrichment in BRCA1-NBR2 CpG island was not observed in the chromatin fraction immunoprecipitated with anti-MBD2 antibodies (Figure 2C), since the amplified segment is unmethylated in HeLa cells (28). Taken together, these data strongly suggest that the methylated region of the BRCA1-NBR2 CpG island is only bound by MBD2 in HeLa cells and that MBD2 binds only to the methylated region.
###end p 44
###begin title 45
###xml 97 107 97 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
Depletion of MBD2 is not compensated by the binding of MeCP2 or MBD1 at the methylated region of BRCA1-NBR2 CpG island
###end title 45
###begin p 46
###xml 46 50 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 56 61 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MeCP2</italic>
###xml 75 77 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 180 182 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 261 271 249 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 540 544 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 639 641 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 656 660 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
HeLa cells contain approximately20 times more MBD2 than MeCP2 transcripts (30). In addition, it has been shown that some methylated DNA regions are bound by multiple MBD proteins (15). Taken together, these data suggest that the specific binding of MBD2 to the BRCA1-NBR2 CpG island might be a consequence of the relative concentrations of the MBD proteins in HeLa cells. To address this issue, MBD proteins binding patterns at this CpG island were investigated in HeLa cells depleted in MBD2. Stable clones, expressing a siRNA targeted to MBD2 transcripts (MBD2a and b isoforms), were constructed by stable transfection of pSUPER vector (33) containing a MBD2 specific insert.
###end p 46
###begin p 47
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 128 137 128 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 287 296 287 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MeCP2</italic>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD1</italic>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
In several HeLa clones, quantitative competitive RT-PCR assays indicated a constitutive reduction of 89-96% in MBD2 mRNA level (Figure 3A, MBD2 KD clones). Western blot analysis also showed a dramatic decrease in MBD2 proteins in these MBD2 KD clones carrying the pSuper-MBD2 transgene (Figure 3B). In addition, persistent suppression of MBD2 expression is conserved after many passages since efficient MBD2 knockdown is still observed after 2 months of continuous culture. Furthermore, the expression of MeCP2 and MBD1 was not affected in MBD2 knockdown clones (KD clones) when compared with the wild-type HeLa cells (data not shown).
###end p 47
###begin p 48
###xml 77 87 77 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 196 205 196 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 370 379 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 596 611 596 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A and B</xref>
###xml 743 747 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sat2</italic>
###xml 846 856 846 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 1037 1046 1037 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1119 1124 1119 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
Quantitative ChIP assays from HeLa cells depleted in MBD2 proteins showed no BRCA1-NBR2 CpG island enrichment in the bound fraction when chromatin is immunoprecipitated with anti-MBD2 antibodies (Figure 4A). Furthermore, as previously observed in HeLa cells, the immunoprecipitated fractions are depleted in the methylated island when anti-MeCP2 or anti-MBD1 were used (Figure 4A). The same results were obtained when a different antibody, anti-MBD1, was used (data not shown). In addition, a positive immunoprecipitation of MeCP2-bound chromatin has been obtained in another set of experiments (Figure 7A and B), and in KD cells additional ChIP control experiments indicated that MBD1 proteins were associated with juxtacentromeric sequences Sat2 (data not shown). Thus, in MBD2-depleted HeLa cells, the methylated region (nt -1244 to -1004) of BRCA1-NBR2 CpG island is not bound by these other two MBD proteins. This observation was extended to the adjacent methylated sequences (nt -1364 to -1218) using a semi-quantitative approach (Figure 4B). Taken together, these data indicate that the methylated region of the BRCA1 island remains free from MeCP2 or MBD1 in MBD2-depleted HeLa cells, suggesting that MBD2 binding is specific.
###end p 48
###begin title 49
###xml 34 44 34 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
Transcriptional repression of the BRCA1-NBR2 locus by MBD2
###end title 49
###begin p 50
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 226 231 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 252 260 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 381 383 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 392 396 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 401 406 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 439 447 427 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 521 525 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 597 601 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 705 714 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 742 744 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 789 794 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 843 847 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 878 887 866 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
The bidirectional promoter, driving both BRCA1 and NBR2 expression, is relatively far (approximately1 kb) from the methylated domain of the CpG island. However, in human cell lines, chemically induced demethylation stimulates BRCA1 gene expression and in vitro methylated expression vectors carrying this CpG island is repressed when transiently transfected into human cell lines (28). Since NBR2 and BRCA1 share the same promoter region (Figure 1), we tested a potential role of DNA methylation in the expression of the NBR2 gene. In HeLa cells, demethylation was induced by 5-aza-dC treatments. NBR2 transcripts were then quantified using a competitive RT-PCR method (a representative assay is shown in Figure 5A). As described previously (28), 5-aza-dC treatment of HeLa cells elevated BRCA1 expression by 1.8-fold and an overexpression of NBR2 (3.1-fold) was also observed (Figure 5B).
###end p 50
###begin p 51
###xml 88 98 88 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 245 254 245 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 310 319 310 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 499 508 499 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
These data raised the question whether MBD2 is a methylation-dependent repressor of the BRCA1-NBR2 bidirectional promoter. In MBD2 depleted cells, a stimulation of NBR2 expression by 1.7-fold is observed when compared with wild-type HeLa cells (Figure 5B). In addition, in MBD2 KD clones, 5-aza-dC treatments (Figure 5B) had a lower effect (1.6-fold) on NBR2 expression than in wild-type cells (3.1-fold). Since both cell types exhibit the same amount of NBR2 transcripts after 5-aza-dC treatments (Figure 5B), these data suggest that MBD2 is an important factor in the NBR2 methylation-dependent control.
###end p 51
###begin p 52
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 105 114 105 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 202 211 202 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 358 368 358 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 573 577 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
However, the same amounts of BRCA1 transcripts were found in MBD2 KD clones and in wild-type HeLa cells (Figure 5B). In addition, BRCA1 response to 5-aza-dC treatment is not modified by MBD2 depletion (Figure 5B), indicating that BRCA1 expression is independent of the MBD2 binding. Furthermore, control experiments indicated that the methylation pattern of BRCA1-NBR2 CpG island was not modified in MBD2 KD cells when compared with the wild-type HeLa cells (Supplementary Data, Figure 9s). Taken together, these data suggest a specific methylation-dependent repression of NBR2 by MBD2.
###end p 52
###begin title 53
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
Mbd2 expression rescues the reduction of NBR2 transcript in MBD2 knockdown clones
###end title 53
###begin p 54
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 538 547 538 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 267 272 <span type="species:ncbi:10090">mouse</span>
Functional control of the specific repression of NBR2 by MBD2 has been performed by expressing the MBD2 target-cDNA in a form that is refractory to siRNA-mediated decay. Five silent point mutations of the third-codon within the targeted region were introduced into a mouse Mbd2 cDNA and the resulting expression vector (pRev-MBD2) was transiently expressed in MBD2 KD clones after transfection. Western blot analysis of HeLa and MBD2 KD clones indicated that Mbd2 proteins were efficiently expressed from the pRev-MBD2 expression vector (Figure 6A).
###end p 54
###begin p 55
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 138 147 138 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 243 248 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 400 410 400 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 514 518 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 531 540 531 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 751 755 751 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 766 775 766 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 810 820 810 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 860 864 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
In wild-type HeLa cells, the level of BRCA1 and NBR2 transcripts was not affected by the Mbd2 overexpression due to the pRev-MBD2 vector (Figure 6B). Also, the pCMV-MBD2 expression vector containing a non-mutated mouse Mbd2 cDNA did not alter BRCA1 and NBR2 transcription in HeLa cells (data not shown). Therefore, the amount of MBD2 is not a limiting factor in the transcriptional repression of the BRCA1-NBR2 locus, in HeLa cells. In contrast, in MBD2 KD cells, pRev-MBD2 expression induced a 28-45% decrease in NBR2 expression (Figure 6B) and transfected MBD2 KD cells exhibited an NBR2 mRNA level equivalent to the level observed in wild-type HeLa cells. No statistically significant decrease in BRCA1 mRNA level was observed in these transfected MBD2 KD cells (Figure 6B). These data confirm that, at the BRCA1-NBR2 locus, MBD2 specifically represses the NBR2 gene.
###end p 55
###begin title 56
Specificity of transcriptional repression by MBD2
###end title 56
###begin p 57
###xml 111 121 111 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
Taken together, these data indicate that, in HeLa cells, under physiological concentrations, MBD2 binds to the BRCA1-NBR2 CpG island and the absence of this protein is not compensated by the binding of other MBD proteins. However, experiments have suggested that exogenous BRCA1 might be repressed by the overexpression of Mecp2 (28). We have, therefore, investigated the ability of the exogenous Mecp2 to repress the transcription of the endogenous locus. Mecp2 was overexpressed in HeLa and MBD2 KD cells by transient transfection of the pCMV-MeCP2-Ha vector. Immunoblots indicated a high expression of Mecp2 after transfection in both cell types (Supplementary Data, Figure 10s).
###end p 57
###begin p 58
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 159 169 147 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 182 190 170 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 279 288 267 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 379 388 367 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 452 456 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 470 479 458 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
###xml 499 503 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 593 598 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 614 618 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 677 686 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
###xml 689 694 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 747 751 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 800 809 788 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
###xml 906 911 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 912 916 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 954 958 942 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
Quantitative ChIP assays, from transfected MBD2 KD cells, showed a slight (approximately1.7-fold) but statistically significant enrichment in the A segment of BRCA1-NBR2 CpG island (Figure 1, 'A' segment) in the chromatin fraction immunoprecipitated by antibodies against MeCP2 (Figure 7A). Mecp2 binding was further confirmed by a semi-quantitative ChIP in the adjacent region (Figure 7B). This Mecp2 binding is associated with a decrease (17-26%) in NBR2 transcripts (Figure 7C), when compared to MBD2 KD cells transfected with an empty vector. In addition, in HeLa cells, overexpression of Mecp2 did not modify NBR2 transcription, as observed after pRev-MBD2 transfections (Figure 7C). BRCA1 mRNA amounts remain unchanged in both wild-type and MBD2 KD HeLa cells expressing MeCP2 at a high level (Figure 7C). Thus, in MBD2 depleted cells, elevated level of exogenous Mecp2 leads to Mecp2 binding at the BRCA1-NBR2 locus and to a partial repression of NBR2.
###end p 58
###begin title 59
DISCUSSION
###end title 59
###begin p 60
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 260 265 <span type="species:ncbi:10090">mouse</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
Transient transfection of in vitro methylated expression vectors has clearly demonstrated that members of the methyl-CpG binding protein family, MBD1, MBD2 and MeCP2, are directly involved in the methylation-dependent repression of gene expression (1). In the mouse, loss of these proteins leads to a prominent effect on cerebral function (17-19), suggesting a specific dependence of these tissues on the control mediated by MBD proteins. Alternatively, functional redundancy between MBD proteins may be more important in other tissues. In line with this hypothesis, global gene overexpression was not observed in mice lacking a particular MBD protein (17-20). Nevertheless, further studies indicated that gene-specific dysregulation in non-cerebral tissues are associated with the loss of MBD proteins (21,22,24). Analysis of the chromatin proteins also raises the question of the redundancy between these proteins.
###end p 60
###begin p 61
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 549 559 525 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 630 640 606 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 1152 1154 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1247 1248 1223 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 1257 1261 1233 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 1305 1310 1281 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MeCP2</italic>
###xml 1335 1337 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1778 1788 1754 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 1173 1178 <span type="species:ncbi:10090">mouse</span>
Our analysis, in the HeLa cell line, of a CpG island at the BRCA1-NBR2 locus indicates that the methylated part of this CpG island is bound by MBD2 while MeCP2 and MBD1 are not detected in this region. Furthermore, western blot analysis, using antibodies directed against MeCP2 and MBD1 produced a signal at the expected size (15), approximately85 and approximately70 kDa, respectively, indicating that both proteins are expressed in this cell line (data not shown). Thus, the lack of detection of these two proteins at the methylated region of the BRCA1-NBR2 CpG island is not due to their absence. In addition, the depletion in BRCA1-NBR2 CpG island in the chromatin fractions immunoprecipitated by the anti-MeCP2 and MBD1 antibodies also indicates that these two proteins are linked to other chromatin domains in HeLa cells. Therefore, the methylated part of this CpG island seems to be specifically associated with MBD2 in our cellular model. Although all the MBD proteins are ubiquitously expressed in somatic tissues, variations in their expression levels, depending on the cell type and the differentiation state, have been observed previously (35). For example, in mouse brain, Mecp2 and Mbd1 are highly expressed when compared with Mbd2 (2), while MBD2 transcripts are 20-fold more abundant than MeCP2 mRNA in breast tissues (30), suggesting that the relative MBD protein concentrations might be involved in the phenotypes associated with their experimental depletions. Therefore, their relative concentrations might be associated with a prominent binding of MBD2 to some methylated DNA segments. However, in these cells, the strong targeted-depletion of MBD2 proteins, induced by RNAi, does not induce the binding of other MBD proteins at the methylated region of the BRCA1-NBR2 CpG island. Thus, these data suggest that this sequence is a preferential target for MBD2.
###end p 61
###begin p 62
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 777 787 777 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 928 935 928 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1049 1059 1049 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 1145 1147 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 1213 1218 1213 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1219 1223 1219 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 179 185 <span type="species:ncbi:10090">murine</span>
Among the mechanisms potentially involved in the preferential binding of MBD2, differences in affinity for methylated DNA might be an important component, since it was shown that murine Mbd2b exhibits a higher affinity than Mecp2 for methylated oligonucleotides (36). Although this possibility cannot be excluded, it should be noted that, in MBD2 knockdown HeLa clones, MBD2 proteins were nearly undetectable and the amount of the transcripts was reduced by 92% on the average, while MeCP2 and MBD1 protein levels remained unchanged (data not shown). In addition, hypermethylated CpG islands are associated with MeCP2 in several cell lines and tissues expressing all MBD proteins (14,15,37,38) and when overexpressed in HeLa cells depleted in MBD2 proteins, Mecp2 binds to the BRCA1-NBR2 CpG island. Taken together, these data suggest that corepressors of transcription leading to a non-permissive chromatin environment may be, in vivo, of importance for the specific recruitment of MBD2, or alternatively for the exclusion of MeCP2 and MBD1 at the BRCA1-NBR2 locus. The possible presence of a recently described MBD2 partner, the MIZF protein (39), has also been investigated, since the methylated region of the BRCA1-NBR2 CpG island contains a consensus binding site for this protein at position -960 bp. However, we failed to detect MIZF at this locus by ChIP (data not shown).
###end p 62
###begin p 63
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 763 768 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 802 806 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 1038 1042 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
In human cell lines, while chemically induced hypomethylation was associated with the activation of both BRCA1 and NBR2, transcriptional repression mediated by MBD2 seemed to be gene specific, since MBD2 knockdown elevated only NBR2 transcription, in HeLa cells. In addition, this phenotype was rescued by exogenous Mbd2, indicating that this effect is a specific consequence of the MBD2 knockdown. Furthermore, this latter experiment also confirmed that MBD2 is not involved in BRCA1 expression, since the expression of exogenous Mbd2 did not modify the amounts of BRCA1 transcripts in both wild-type HeLa cells and MBD2 KD cells. Moreover, the response of NBR2 to DNA hypomethylation was reduced by a factor of approximately2 in MBD2-depleted HeLa cells, while BRCA1 response was not affected by the MBD2-siRNA. Although MBD2 depletion does not completely abolish the effect of 5-aza-dC, the consistent reduction of 5-aza-dC-response in MBD2-depleted HeLa cells confirms that MBD2 significantly contributes to the methylation-dependent NBR2 repression.
###end p 63
###begin p 64
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 654 658 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
In the human genome, BRCA1 lies head to head with the NBR2 gene (40). The transcription start site of BRCA1 is separated from the NBR2 gene by a 218 bp bidirectional promoter (40,41). This region is embedded within a large CpG island (13) and the methylated part of this region corresponds to a nuclease resistant chromatin structure in human breast cell lines (29) and in HeLa cells. Hence, this region is located at the 3' end of the NBR2 transcription start site and at the 5' end of BRCA1 (Figure 1). The specificity of MBD2 towards NBR2 transcription from the bidirectional BRCA1-NBR2 promoter, suggests that the methylation-dependent repression of NBR2 and BRCA1 is mediated by different mechanisms.
###end p 64
###begin p 65
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1063 1068 1063 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 1271 1276 1271 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1287 1289 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 67 72 <span type="species:ncbi:9606">human</span>
The analysis of the 5' region of the endothelin receptor B gene in human cell lines shows that extensive methylation closely downstream of the initiation site does not abolish gene expression (42). However, studies using plasmid and episomal vectors (43-45) and patch methylation techniques indicate that methylation downstream of a promoter can decrease transcription levels, suggesting that this epigenetic mark may also affect the elongation rate. Therefore, the reduced expression of NBR2 mediated by MBD2 might be dependent on such mechanisms. In line with this hypothesis, BRCA1 expression is not affected by MBD2 binding to the methylated region of the CpG island upstream its promoter. Nevertheless, inhibition of DNA methylation stimulates BRCA1 expression, suggesting that its repression might be associated with the binding of different MBD proteins to some other methylated DNA segments. Alternatively, DNA methylation may have a direct effect on the binding of regulatory factors since it was suggested that the -1582 to -202 region of the 5' end of BRCA1 contains several weak regulatory sites (both enhancers and repressors) with additive effects (40) and a putative cAMP-responsive element binding transcription factor binding site has been mapped in the BRCA1 promoter (46).
###end p 65
###begin p 66
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il4</italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 296 301 <span type="species:ncbi:10090">mouse</span>
MBD2 belongs to a family of methylation-dependent transcriptional repressor and its presence in aberrantly methylated genes has been observed in human cancer cell lines (47-49). However, a direct relationship between MBD2 binding and gene repression has been established only for a few genes. In mouse, it had been shown that Gata-3 and Mbd2 act in competition for the regulation of Il4 gene transcription in T-helper cells (49). Evidences for a contribution of MBD2 in silencing the aberrantly methylated pi-class glutathione S-transferase (GSTP1) promoter have been obtained, in the breast cancer cell line MCF7 cells, by MBD2-depletion mediated by siRNA (48).
###end p 66
###begin p 67
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 507 509 507 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1</italic>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 793 797 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 890 894 890 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 894 897 894 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1206 1210 1206 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 1210 1213 1210 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1259 1264 1259 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1295 1299 1295 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 1316 1318 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 333 348 <span type="species:ncbi:10633">Simian virus 40</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
Functional domains have been mapped within the MBD proteins and beside their methyl-CpG binding domain, all these proteins posses a domain involved in gene repression, the transcriptional repression domains (TRDs); in contrast to the MBD, no sequence similarities were found between the different TRDs (1). Many promoters, including Simian virus 40, cytomegalovirus and beta-actin promoters (3), are efficiently repressed by tethering the minimal TRD of MeCP2, MBD1 and MBD2. However, it was shown that the L1 promoter is not repressed by fusion protein containing the TRD of MBD2, but is silenced by fusion proteins containing either MeCP2 or MBD1 TRDs (50). The repression of NBR2 by MBD2 does not seem to be specific of its TRD, since in MBD2-depleted HeLa cells, exogenous Mecp2 decreased NBR2 transcription. Similarly, inhibitory effect of exogenous Mecp2 has already been observed in Mbd2-/- mice. Indeed, previous studies have shown that the methylation-dependent repression of reporter genes is impaired in fibroblast cell lines from these mice, suggesting that endogenous Mecp2 proteins do not compensate for the absence of Mbd2 (18). Nevertheless, exogenous Mecp2 restores full repression in the Mbd2-/- cells, indicating that the overexpression of Mecp2 can counteract the absence of Mbd2 in this system (18).
###end p 67
###begin p 68
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mbd2</italic>
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 141 146 141 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 229 237 229 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 591 595 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 285 294 <span type="species:ncbi:10090">nude mice</span>
Although Mbd2-/- mice are viable and fertile (20), a reduction in Mbd2 inhibits the development of intestinal adenomas in the tumor-prone ApcMin/+ mouse (51). In human cell lines, MBD2 antisense inhibitors suppress tumorigenesis in vitro and in vivo, when these cells are implanted in nude mice as a model (52). Taken together these data suggest that MBD2 represents a new target potential in cancer therapy and, therefore, new insights on MBD2 specificities are, in this context, of importance. Collectively, our data indicate that MBD2 specifically binds to the BRCA1 island and represses NBR2. In addition, our results suggest that the relative abundance of MBD is not a major factor in their targeting to some methylated DNAs. Furthermore, the cellular model developed in this study may represent a valuable tool for the identification of MBD2 target genes, which could be valuable for therapeutics applications.
###end p 68
###begin title 69
SUPPLEMENTARY MATERIAL
###end title 69
###begin p 70
Supplementary Material is available at NAR Online.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
[Supplementary Material]
###end title 72
###begin p 73
We are most grateful to Dr Paul Wade for providing MBD2 antibodies and to Dr Adrian Bird for the pCMV-MeCP2-HA and pCMV-MBD2 vectors. This work was supported by the Ligue Nationale contre le Cancer (Comite du Rhone and Comite de la Loire), France and the Association pour la Recherche sur le Cancer, France. Funding to pay the Open Access publication charges for this article was provided by Centre Leon Berard, Lyon, France.
###end p 73
###begin p 74
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 74
###begin title 75
REFERENCES
###end title 75
###begin article-title 76
Methylation-induced repression-belts, braces, and chromatin
###end article-title 76
###begin article-title 77
Identification and characterization of a family of mammalian methyl-CpG binding proteins
###end article-title 77
###begin article-title 78
Methyl CpG-binding proteins and transcriptional repression
###end article-title 78
###begin article-title 79
The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation
###end article-title 79
###begin article-title 80
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
###end article-title 80
###begin article-title 81
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
###end article-title 81
###begin article-title 82
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
###end article-title 82
###begin article-title 83
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
###end article-title 83
###begin article-title 84
The minimal repression domain of MBD2b overlaps with the methyl-CpG-binding domain and binds directly to Sin3A
###end article-title 84
###begin article-title 85
Active repression of methylated genes by the chromosomal protein MBD1
###end article-title 85
###begin article-title 86
Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression
###end article-title 86
###begin article-title 87
Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly
###end article-title 87
###begin article-title 88
###xml 52 57 <span type="species:ncbi:9606">human</span>
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1
###end article-title 88
###begin article-title 89
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes
###end article-title 89
###begin article-title 90
###xml 79 84 <span type="species:ncbi:9606">human</span>
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer
###end article-title 90
###begin article-title 91
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
###end article-title 91
###begin article-title 92
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
###end article-title 92
###begin article-title 93
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
###end article-title 93
###begin article-title 94
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function
###end article-title 94
###begin article-title 95
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development
###end article-title 95
###begin article-title 96
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2
###end article-title 96
###begin article-title 97
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation
###end article-title 97
###begin article-title 98
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome
###end article-title 98
###begin article-title 99
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Gene silencing quantitatively controls the function of a developmental trans-activator
###end article-title 99
###begin article-title 100
###xml 51 56 <span type="species:ncbi:9606">human</span>
DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells
###end article-title 100
###begin article-title 101
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene
###end article-title 101
###begin article-title 102
DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter
###end article-title 102
###begin article-title 103
###xml 101 106 <span type="species:ncbi:9606">human</span>
Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells
###end article-title 103
###begin article-title 104
Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter
###end article-title 104
###begin article-title 105
###xml 71 76 <span type="species:ncbi:9606">human</span>
MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland
###end article-title 105
###begin article-title 106
###xml 52 57 <span type="species:ncbi:9606">human</span>
BRCA1 expression during prenatal development of the human mammary gland
###end article-title 106
###begin article-title 107
###xml 34 39 <span type="species:ncbi:9606">human</span>
Abundance of BRCA1 transcripts in human cancer and lymphoblastoid cell lines carrying BRCA1 germ-line alterations
###end article-title 107
###begin article-title 108
A system for stable expression of short interfering RNAs in mammalian cells
###end article-title 108
###begin article-title 109
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
###end article-title 109
###begin article-title 110
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA
###end article-title 110
###begin article-title 111
The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties
###end article-title 111
###begin article-title 112
###xml 98 103 <span type="species:ncbi:9606">human</span>
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation
###end article-title 112
###begin article-title 113
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation
###end article-title 113
###begin article-title 114
Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF
###end article-title 114
###begin article-title 115
Positive regulation of the BRCA1 promoter
###end article-title 115
###begin article-title 116
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
Complex regulation of the BRCA1 gene
###end article-title 116
###begin article-title 117
The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells
###end article-title 117
###begin article-title 118
Stability of patch methylation and its impact in regions of transcriptional initiation and elongation
###end article-title 118
###begin article-title 119
Inactive chromatin spreads from a focus of methylation
###end article-title 119
###begin article-title 120
Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells
###end article-title 120
###begin article-title 121
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site
###end article-title 121
###begin article-title 122
Methyl-CpG-binding proteins. Targeting specific gene repression
###end article-title 122
###begin article-title 123
Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells
###end article-title 123
###begin article-title 124
###xml 94 99 <span type="species:ncbi:9606">human</span>
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia
###end article-title 124
###begin article-title 125
Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription
###end article-title 125
###begin article-title 126
Deficiency of Mbd2 suppresses intestinal tumorigenesis
###end article-title 126
###begin article-title 127
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo
###end article-title 127
###begin title 128
Figures and Tables
###end title 128
###begin p 129
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1-NBR2</italic>
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
The BRCA1-NBR2 locus. The BRCA1 gene is located head to head with the NBR2 gene and the two genes are separated by a bidirectionnal promoter (25). Transcription start sites of both genes are arrowed in black. Black box, BRCA1 and NBR2 exons. The locus includes a CpG island of 2784 bp in length (%G+C, 57; ObsCpG/ExpCpG, 0.65; CpGProD software, ). M+, constitutively methylated region of the CpG island (28); light gray box, LTR12c retroelement; dark gray box, AluY sequence (Repeat Masker software, version 2002). Black lines represent the positions of the fragments amplified by A, competitive PCR; B, C, D and 'promoter', semi-quantitative PCR, after ChIP. Positions are indicated from the BRCA1 transcription start site.
###end p 129
###begin p 130
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 773 778 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 892 893 892 893 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 999 1007 999 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 1329 1330 1329 1330 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1450 1455 1450 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1520 1525 1520 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 295 301 <span type="species:ncbi:9986">rabbit</span>
###xml 360 365 <span type="species:ncbi:10090">mouse</span>
MBD2 associates the methylated region of the BRCA1 CpG island in HeLa cells. (A) Amounts of immunoprecipitated BRCA1 island (fragment A, see Figure 1) measured by competitive PCR (error bars, SD from, at least, three independent experiments). Cross-linked chromatin was immunoprecipitated using rabbit polyclonal anti-MBD2, anti-MeCP2, anti-MBD1 or monoclonal mouse anti-MBD1 antibodies. Purified DNA from the input, unbound or bound fractions was quantified and quantitative PCR analysis was accomplished. Then, the intensity of the bands corresponding to the PCR products was plotted against the initial number of competitor molecules as described in Supplementary Data, Figure 8s. Black box, amount of BRCA1 island fragments per ng of the input DNA. Open box, amount of BRCA1 island fragments per ng of the unbound DNA. Gray box, amount of BRCA1 island fragments per ng of the bound DNA. (B) Three other regions of the BRCA1 CpG island were analyzed by ChIP. These regions, fragments B, C and D (Figure 1), are located upstream the first region amplified by competitive PCR. After immunoprecipitation, purified DNA from the different fractions was quantified and 0.5 ng of this DNA was amplified. The intensities of the bands corresponding to the PCR products amplified from the input, unbound and bound fractions are shown. (C) Representative experiment of PCR amplification of an unmethylated region including the promoter and the exon 1 of the BRCA1 gene ('promoter fragment' from position -56 to +263 bp from the BRCA1 transcription start site) on MBD2-ChIP fractions.
###end p 130
###begin p 131
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 310 314 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 479 483 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 523 524 521 522 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 631 637 <span type="species:ncbi:9986">rabbit</span>
###xml 702 707 <span type="species:ncbi:10090">mouse</span>
MBD2 mRNA and protein quantification in HeLa cells expressing stable siRNA (MBD2 knockdown cells). (A) Quantification of MBD2 mRNA by competitive RT-PCR assay in wild-type HeLa and three clones of MBD2 knockdown cells (a, b and c) performed from 0.1 mug of total RNA mixed with increasing amount of competitor MBD2 RNA. The intensity of the bands corresponding to the PCR products was plotted against the initial number of competitor molecules in order to estimate the amount of MBD2 mRNA present in 1 mug of each sample. (B) Immunoblot analysis of MBD2 proteins in HeLa and knockdown cell lines. MBD2 proteins were probed using a rabbit polyclonal antibody. Then, the same membrane was probed using a mouse beta-tubulin antibody as a loading control.
###end p 131
###begin p 132
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 112 113 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 481 482 481 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 552 560 552 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 599 608 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
MeCP2 and MBD1 do not compensate for MBD2 depletion at the BRCA1-NBR2 CpG island in MBD2 knockdown HeLa cells. (A) Amounts of immunoprecipitated BRCA1 island (fragment A, Figure 1) measured by competitive PCR (error bars, SD from, at least, three independent experiments). Black box, amount of BRCA1 island fragments per ng of the input DNA. Open box, amount of BRCA1 island fragments per ng of the unbound DNA. Gray box, amount of BRCA1 island fragments per ng of the bound DNA. (B) Representative examples of BRCA1 semi-quantitative PCR (fragment B, Figure 1) on MBDs-ChIP assays (as described in Figure 2B).
###end p 132
###begin p 133
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 91 92 91 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 218 222 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 286 287 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 299 300 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 316 317 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 329 330 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 346 347 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 660 664 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 703 707 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 714 715 713 714 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 717 721 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 726 731 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 762 766 761 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 941 945 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 1022 1027 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1033 1035 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
Effects of 5-aza-dC on the expression of BRCA1 and NBR2 in HeLa and MBD2 knockdown cells. (A) Quantitative competitive RT-PCR assay of NBR2 mRNAs was performed from 0.6 mug of total RNA mixed with increasing amount of NBR2 competitor RNA. Amounts of competitor molecules: lane 1, 5 x 104; lane 2, 105; lane 3, 5 x 105; lane 4, 106; lane 5, 5 x 106. The RT-PCR products were analyzed on a 2% agarose gel containing ethidium bromide. The intensity of the bands corresponding to the PCR products was plotted against the initial number of competitor molecules. The diagrams of the intensity values are represented below the gels. Black box, 349 bp band competitor NBR2 RNA; open box, 458 bp band endogenous NBR2 RNA. (B) NBR2 and BRCA1 transcripts in HeLa cells and MBD2 KD cells treated or untreated with 10 muM 5-aza-dC for 72 h. Quantitative RT-PCR analyses were performed from 0.6 mug of total RNA mixed with increasing amount of competitor NBR2 RNA or from 0.3 mug of total RNA mixed with increasing amount of competitor BRCA1 RNA (32). Average values obtained from four independent experiments (error bar, SD) are shown. Control: untreated cells.
###end p 133
###begin p 134
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 65 66 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 456 457 456 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 573 577 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 862 863 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 882 883 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 427 433 <span type="species:ncbi:9986">rabbit</span>
MBD2 transfection experiments in HeLa and MBD2 knockdown cells. (A) Immunoblot analysis of MBD2 proteins in HeLa and MBD2 KD cells transfected with an MBD2 vector expressing a transcript resistant to RNAi (pRev-MBD2 vector). HeLa and MBD2 KD cells were transfected with the pRev-MBD2 vector or with an empty pGL3 basic vector (pGL3). MBD2 proteins, from whole cell extract prepared 48 h after transfection, were probed using a rabbit polyclonal antibody. (B) Quantitative RT-PCR analysis of BRCA1 and NBR2 transcripts was performed (as described in Figure 5) from HeLa and MBD2 KD cells transfected with the pRev-MBD2 or an empty vector (pGL3). The ratio between the amounts of the transcripts in pRev-MBD2-transfected cells and pGL3-transfected cells was then calculated. Mean values obtained from at least four independent transfection experiments are shown [*P = 0.0049 (<0.05), t-test].
###end p 134
###begin p 135
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 280 288 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 321 329 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 407 408 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 481 489 481 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 602 603 602 603 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBR2</italic>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBD2</italic>
###xml 945 946 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 965 966 965 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
MeCP2 transfection experiments in HeLa and MBD2 knockdown cells. (A) Quantitative MeCP2-ChIP assays in MBD2 KD cells transfected with the pCMV-MeCP2-HA vector. After immunoprecipitation of cross-linked chromatin with an anti- MeCP2 antibody, competitive PCR analysis (fragment A, Figure 1) was performed (as described in Figure 2). Average values obtained from two independent MeCP2-ChIP assays are shown. (B) A representative example of a BRCA1 semi-quantitative PCR (fragment B, Figure 1) performed on these ChIP assays. See Supplementary Results for immunoblot controls (Supplementary Figure 10s). (C) BRCA1 and NBR2 mRNA quantification in HeLa and MBD2 KD cells transfected with an MeCP2 vector. Four independent transfection experiments of HeLa and MBD2 KD cells with the pCMV-MeCP2-HA vector or an empty pGL3 basic vector (pGL3), RNA extraction and quantitative RT-PCR analysis were performed. Average values are presented on this graph [*P = 0.018 (< 0.05), t-test].
###end p 135

